Jim Simons
AVXL icon

Jim Simons’s Anavex Life Sciences AVXL Stock Holding History

Jim Simons’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-276,800
Closed -$850K – 3195
2026
Q1 		$850K Buy
276,800
+251,378
+989% +$1.09M ﹤0.01% 2349
2025
Q4 		$90.5K Buy
+25,422
New +$156K ﹤0.01% 3022
2025
Q2 		– Sell
-14,000
Closed -$120K – 3548
2025
Q1 		$120K Sell
14,000
-199,200
-93% -$1.88M ﹤0.01% 3164
2024
Q4 		$2.29M Sell
213,200
-30,600
-13% -$235K ﹤0.01% 1972
2024
Q3 		$1.38M Sell
243,800
-222,637
-48% -$1.28M ﹤0.01% 2249
2024
Q2 		$1.97M Buy
466,437
+386,537
+484% +$1.56M ﹤0.01% 1896
2024
Q1 		$407K Buy
+79,900
New +$450K ﹤0.01% 2954
2022
Q4 		– Sell
-367,100
Closed -$3.79M – 4109
2022
Q3 		$3.79M Buy
367,100
+9,300
+3% +$98.1K 0.01% 1609
2022
Q2 		$3.58M Buy
+357,800
New +$3.39M ﹤0.01% 1790
2021
Q1 		– Sell
-63,100
Closed -$341K – 3300
2020
Q4 		$341K Buy
+63,100
New +$333K ﹤0.01% 2988
2020
Q2 		– Sell
-407,400
Closed -$1.28M – 3426
2020
Q1 		$1.28M Buy
407,400
+325,859
+400% +$1.14M ﹤0.01% 2303
2019
Q4 		$211K Buy
+81,541
New +$214K ﹤0.01% 3184
2019
Q1 		– Sell
-18,109
Closed -$28K – 3437
2018
Q4 		$28K Buy
+18,109
New +$41.1K ﹤0.01% 3312

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Summit Financial
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jim Simons's AVXL Position: Q2 2026 in Review

Jim Simons sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 276,800 shares — an estimated $850K sold.

Jim Simons first reported a position in AVXL in Q4 2018 and held it in 13 quarters. The position peaked at $3.79M in Q3 2022. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Jim Simons reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 276,800 Anavex Life Sciences shares in Q2 2026, an estimated $850K.
  • Jim Simons first reported a position in Anavex Life Sciences in Q4 2018 and held it in 13 quarters.
  • Jim Simons's Anavex Life Sciences position peaked at $3.79M in Q3 2022.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.